LEXAPRIM Tablets / Film-coated
Escitalopram
15mg
Laboratorios Cinfa S.A
| Pack size | 28's (7's Blister x 4) |
|---|---|
| Dispensing mode | POM |
| Source | SPAIN |
| Agent | ALPHAMED DRUG STORE |
| Retail Price | 81.00 AED |
Available as:
Indications
LEXAPRIM Tablets / Film-coated is used for:
Major depressive disorder, Depression, Panic disorder, Obsessive compulsive disorder, Anxiety disorder
Adult Dose
Oral
Anxiety; Depression; Obsessive compulsive disorder
Adult: 10 mg once daily, increased after at least a wk if needed. Max: 20 mg once daily.
Panic disorder with or without agoraphobia
Adult: Initially, 5 mg once daily, increased after a wk to 10 mg once daily. Max: 20 mg daily.
Elderly: Half the adult dose.
Hepatic impairment: Mild to moderate: Initially, 5 mg daily, increased to 10 mg daily after 2 wk if needed. Severe: More careful dose titration needed.
Child Dose
Major Depressive Disorder
<12 years: Safety and efficacy not established
>12 years: 10 mg PO qDay; may increase dose after at least 3 weeks; not to exceed 20 mg/day
Renal Dose
Administration
May be taken with or without food.
Contra Indications
Concomitant use with or within 2 wk of MAOI withdrawal.
Precautions
History of mania or seizure disorders; work requiring mental alertness; renal and hepatic impairment; pregnancy, lactation; withdraw gradually.
Lactation
Excreted in breast milk; consider risk/benefit ratio
Pregnancy-Lactation
Pregnancy
There are no adequate and well-controlled studies in pregnant women; therefore, use during pregnancy only if the potential benefit justifies the potential risk to the fetus
In some cases, the clinical picture is consistent with serotonin syndrome
Effect on labor and delivery in humans is unknown
Neonates exposed to escitalopram and other SSRIs/SNRIs
Neonates exposed to SSRIs/SNRIs late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding
Such complications can arise immediately upon delivery
Reported clinical findings include respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hypotonia, hypertonia, hyperreflexia, tremor, jitteriness, irritability, and constant crying
These features are consistent with toxic effects of SSRIs and SNRIs or, possibly, drug discontinuation syndrome
Lactation
Escitalopram is excreted in human breast milk
Limited data from women taking 10-20 mg escitalopram showed that exclusively breast-fed infants receive a ~3.9% of the maternal weight-adjusted dose of escitalopram and 1.7% of the maternal weight-adjusted dose of desmethylcitalopram
Caution should be exercised and breastfeeding infants should be observed for adverse reactions when administered to a nursing woman
Interactions
Increased risk of bleeding when used with aspirin, NSAIDs or drugs that affect coagulation. Serum levels may be reduced by CYP2C19 inducers (e.g. carbamazepine, rifampin, phenytoin) or CYP3A4 inducers (e.g. nafcillin, nevirapine). Serum levels may also be increased by CYP2C19 inhibitors (e.g. fluconazole, fluvoxamine, omeprazole) or CYP3A4 inhibitors (e.g. azole antifungals, clarithromycin). May increase serum levels of desipramine or metoprolol. Increased risk of serotonin syndrome when used with linezolid or sibutramine. Escitalopram may enhance the sedative effects of alcohol.
Potentially Fatal: Concomitant administration with MAOIs may lead to serious or fatal reactions; should not be started until at least 2 wk after stopping escitalopram or vice versa. Moclobemide may increase the risk of serotonin syndrome.
Adverse Effects
Side effects of Escitalopram :
>10%
Headache (24%), Nausea (18%), Ejaculation disorder (9-14%), Somnolence (4-13%), Insomnia (7-12%)
1-10%
Xerostomia (4-9%), Constipation (3-6%), Fatigue (2-8%), Libido decrease (3-7%), Anorgasmia (2-6%), Flatulence (2%), Toothache (2%), Weight gain (1%), Menstrual disorder (2%), Neck/shoulder pain (3%), Rhinitis (5%), Flu-like syndrome (5%), Ejaculation disorder (9-14%)
<1%
Arthralgia, Abdominal pain, Abnormal bleeding, Abnormal dreams, Allergy, Blurred vision, Bronchitis, Chest pain, Constipation, Decreased appetite, Decreased concentration, Disrupts platelets/hemostasis, Dizziness, Dyspepsia, Fever, Heartburn, Hot flashes, Impotence, Irritability, Jaw stiffness, Lethargy, Lightheadedness, Menstrual disorder, Hypertension, Palpitations, Migraine, Myalgia, Paresthesia, Rash, Sweating, Tinnitus, Tremor, Urinary frequency, Urinary tract infection, Vertigo, Vomiting, Yawning
Mechanism of Action
Escitalopram selectively inhibits CNS neuronal re-uptake of serotonin (5-HT) and potentiates serotonergic activity. It has minimal effects on norepinephrine and dopamine neuronal re-uptake.
Note
LEXAPRIM 15mg Tablets / Film-coated manufactured by Laboratorios Cinfa S.A. Its generic name is Escitalopram. LEXAPRIM is availble in United Arab Emirates.
Farmaco UAE drug index information on LEXAPRIM Tablets / Film-coated is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Escitalopram :
Tablets / Film-coated
Xeforam
20mg
WYETH PHARMACEUTICALS LLC- REPRESENTATIVE OFFICE
Tablets / Film-coated
Xeforam
20mg
WYETH PHARMACEUTICALS LLC- REPRESENTATIVE OFFICE
Tablets / Film-coated
Xeforam
10mg
WYETH PHARMACEUTICALS LLC- REPRESENTATIVE OFFICE
Tablets / Film-coated
Xeforam
10mg
WYETH PHARMACEUTICALS LLC- REPRESENTATIVE OFFICE
Tablets / Film-coated
Tabupram
20mg
Tabuk Pharmaceutical Manufacturing Co.